Insider · CIK 0001910331
Thomas James Doyle
officer
Files at KURA (Kura Oncology, Inc.). First filing Jan 28, 2025, latest Sep 29, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $179k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KURA: Kura Oncology, Inc.
KURAOct 9, 2026 · close 10.60
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Kura Oncology, Inc. | $48k 4,607 shares | -3% | - | |
| 37Weak | Kura Oncology, Inc. | $51k 4,539 shares | -3% | +102% from low-32% from high | |
| 36Weak | Kura Oncology, Inc. | $41k 4,541 shares | -4% | +62% from low-54% from high | |
| 36Weak | Kura Oncology, Inc. | $39k 4,949 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,607 | $10.50 | $48k | 142,428 | 13 d ago |
| Nov 13, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +24,967 | $0.00 | $0 | 134,796 | Nov 14, 2025 |
| Nov 14, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,539 | $11.18 | $51k | 130,257 | Nov 14, 2025 |
| Sep 27, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +24,966 | $0.00 | $0 | 114,370 | Sep 29, 2025 |
| Sep 29, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -4,541 | $8.94 | $41k | 109,829 | Sep 29, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -2,241 | $7.87 | $18k | 90,901 | Jan 28, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -887 | $7.87 | $6,982 | 90,014 | Jan 28, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -699 | $7.87 | $5,502 | 89,315 | Jan 28, 2025 |
| Jan 28, 2025 | KURA Kura Oncology, Inc. | SOpen-market sale Common Stock | -1,122 | $7.87 | $8,832 | 88,193 | Jan 28, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +21,250 | $0.00 | $0 | 71,892 | Jan 6, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Common Stock | +21,250 | $0.00 | $0 | 93,142 | Jan 6, 2025 |
| Jan 2, 2025 | KURA Kura Oncology, Inc. | AGrant or award Option to purchase common stockderivative | +42,500 | $0.00 | $0 | 42,500 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.